DDX6 | DEAD (Asp-Glu-Ala-Asp) box helicase 6 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DEK | DEK oncogene | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
DICER1 | Dicer 1, ribonuclease type III | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DNM2 | Dynamin 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
ECT2L | Epithelial cell transforming sequence 2 oncogene-like | Cancer-related genes
| | | | | Tissue enriched |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF4A2 | Eukaryotic translation initiation factor 4A2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
ELF4 | E74-like factor 4 (ets domain transcription factor) | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ELK4 | ELK4, ETS-domain protein (SRF accessory protein 1) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ELL | Elongation factor RNA polymerase II | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ELN | Elastin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
EML4 | Echinoderm microtubule associated protein like 4 | Cancer-related genes
| | | | | Expressed in all |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EPS15 | Epidermal growth factor receptor pathway substrate 15 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERC1 | ELKS/RAB6-interacting/CAST family member 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ERG | V-ets avian erythroblastosis virus E26 oncogene homolog | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ETV4 | Ets variant 4 | Cancer-related genes Transcription factors
| | | | | Mixed |
ETV5 | Ets variant 5 | Cancer-related genes Transcription factors
| | | | | Mixed |
ETV6 | Ets variant 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
EWSR1 | EWS RNA-binding protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FAM46C | Family with sequence similarity 46, member C | Cancer-related genes
| | | | | Mixed |
FAS | Fas cell surface death receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FBXO11 | F-box protein 11 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FCRL4 | Fc receptor-like 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
FGFR1 | Fibroblast growth factor receptor 1 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FHIT | Fragile histidine triad | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
FIP1L1 | Factor interacting with PAPOLA and CPSF1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
FNBP1 | Formin binding protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXO1 | Forkhead box O1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOXO3 | Forkhead box O3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
FOXP1 | Forkhead box P1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
FSTL3 | Follistatin-like 3 (secreted glycoprotein) | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
FUBP1 | Far upstream element (FUSE) binding protein 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
FUS | Fused in sarcoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
GAS7 | Growth arrest-specific 7 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GMPS | Guanine monphosphate synthase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |